Hello, Fool! | Login | Signup | My Fool
Oct 13, 2008 10:15 AM ET | Feedback | Site Changes | Help
The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.
View All Commentary (ISIS)
Recs
xthecritic (50.43) Submitted: 2/08/08 10:29 AM : Start Price: $15.47 ISIS Score: 13.82
Genzyme just valued the stock at $30 per share.... they know more than I do.-- Prophet of Portsmouth
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK